T-Thesys therapy is an innovative treatment that can be used even in the presence of recent injuries. For this reason, we studied the T-Thesys use in the post-operative phase of the anterior cruciate ligament (ACL) reconstruction of the knee. For our study, we selected 51 patients for ACL surgery, and we divided participants in two groups: the Experimental Group (EG) and the Control Group (CG). The EG consisted of 34 patients (age: 26.9 ± 7.65 years) who underwent T-Thesys therapy after surgery, while the CG included 17 patients (age: 26.7 ± 6.8 years) who was not subjected to T-Thesys therapy after surgery. T-Thesys therapy was performed on a daily basis and participants' parameters were monitored throughout the treatment. For the EG, we did not find any significant differences, however, subjective disorders seemed to disappear, almost entirely, at the seventh application. The CG showed no significant differences, even in the subjective disorders investigated. Therefore, the therapeutic treatment associated with T-Thesys therapy seems to not show any efficacy compared to the surgical treatment alone. However, from our findings emerged differences which tend to highlight a better clinical response, a faster recovery time, an improvement on the quality of life in patients, and, moreover, a better use of the National Health System resources.
Application of T-Thesys Therapy in post-operative recovery in knee-surgical interventions: A case study
Francavilla, Vincenzo Cristian
;
2020-01-01
Abstract
T-Thesys therapy is an innovative treatment that can be used even in the presence of recent injuries. For this reason, we studied the T-Thesys use in the post-operative phase of the anterior cruciate ligament (ACL) reconstruction of the knee. For our study, we selected 51 patients for ACL surgery, and we divided participants in two groups: the Experimental Group (EG) and the Control Group (CG). The EG consisted of 34 patients (age: 26.9 ± 7.65 years) who underwent T-Thesys therapy after surgery, while the CG included 17 patients (age: 26.7 ± 6.8 years) who was not subjected to T-Thesys therapy after surgery. T-Thesys therapy was performed on a daily basis and participants' parameters were monitored throughout the treatment. For the EG, we did not find any significant differences, however, subjective disorders seemed to disappear, almost entirely, at the seventh application. The CG showed no significant differences, even in the subjective disorders investigated. Therefore, the therapeutic treatment associated with T-Thesys therapy seems to not show any efficacy compared to the surgical treatment alone. However, from our findings emerged differences which tend to highlight a better clinical response, a faster recovery time, an improvement on the quality of life in patients, and, moreover, a better use of the National Health System resources.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
